Intestinal and Extra-Intestinal Manifestations of Campylobacter in the Immunocompromised Host

AbstractPurpose of reviewDescribe most recent data on manifestations and treatment of intestinal and extra-intestinal manifestations of Campylobacter among immunocompromised patients.Recent findingsResistance to fluoroquinolones, macrolides, and tetracycline challenge traditional empiric therapies.SummaryRecurrent Campylobacter enteritis and bacteremia are associated with hypogammaglobinemia, HIV, transplant-associated immunotherapy, and hematologic malignancies.C. jejuni andC. coli are the most commonly associated Campylobacter species althoughC. fetus,C. upsaliensis,C. lari,C. curvus, andC. rectus should be considered as potential causative agents of rare extra-intestinal infections. Successful diagnosis and treatment of these cases may require the recognition of the limits of standard diagnostics and the recent emergence of highly resistant strains of Campylobacter, particularlyC. coli.
Source: Current Treatment Options in Infectious Diseases - Category: Infectious Diseases Source Type: research